ЦУКРОВИЙ ДІАБЕТ ТА ЕКЗОКРИННА НЕДОСТАТНІСТЬ ПІДШЛУНКОВОЇ ЗАЛОЗИ: СУЧАСНИЙ ПОГЛЯД НА ПРОБЛЕМУ
Open Access
- 15 December 2025
- journal article
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 82 (4) , 35-43
Abstract
Exocrine pancreatic insufficiency (EPI) is increasingly recognized as a common comorbidity in both type 1 and type 2 diabetes mellitus (DM), which remains largely underdiagnosed due to nonspecific clinical manifestations and the lack of standardized screening protocols. The aim of this article is to summarize current evidence regarding the pathophysiological mechanisms, epidemiology, clinical features, diagnostic algorithms, and treatment strategies for EPI in patients with DM. A literature search was conducted using the databases Web of Science, Scopus, The Cochrane Library, MedLine, EMBASE, Global Health, etc. The paper highlights the close functional interdependence between the endocrine and exocrine compartments of the pancreas, in which dysfunction of one component often leads to impairment of the other. It is shown that the development of EPI is driven by insulin deficiency (especially in type 1 DM), insulin resistance (type 2 DM), oxidative and endoplasmic stress, autoimmune inflammation, microangiopathy, and the influence of certain nutrients (fructose, ethanol, BCAAs). The clinical relevance of EPI is substantiated in the context of impaired nutritional status, fat-soluble vitamin deficiency, sarcopenia, maldigestion, reduced quality of life, and glycemic variability. Diagnostic criteria are reviewed with particular emphasis on fecal elastase-1 as a widely accessible screening marker. The article provides an overview of current evidence on the efficacy of pancreatic enzyme replacement therapy (PERT), particularly with pancrelipase, which not only alleviates symptoms of maldigestion but also improves glycemic control, nutritional indices, reduces the frequency of hypoglycemia, and attenuates systemic inflammation. Data from clinical studies confirm the safety and efficacy of long-term PERT even in patients without overt signs of EPI. The need for the development and implementation of national clinical protocols for EPI screening and management in DM, aligned with modern international guidelines (UEG, AGA, ESPEN), is emphasized. These approaches have the potential to improve metabolic control, nutritional status, and reduce diabetes-related complications, especially in patients with comorbid conditions.Keywords
This publication has 27 references indexed in Scilit:
- Pancreatic Enzyme Replacement Therapy in Pancreatic Exocrine Insufficiency—Real-World’s Dosing and Effectiveness: A Systematic ReviewDigestive Diseases and Sciences, 2025
- European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendationsUnited European Gastroenterology Journal, 2024
- Pancreatic Enzyme Replacement Leads to Increased Vitamin D Uptake in Patients Undergoing Sleeve-gastrectomy — A Prospective, Monocentric TrialObesity Surgery, 2024
- Is endocrine and exocrine function improved following duodenal preserving pancreatic head resection over whipple for chronic pancreatitis?HPB, 2022
- Exocrine Pancreatic Insufficiency in Type 1 and Type 2 DiabetesCurrent Diabetes Reports, 2020
- Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: do we need to treat it? A systematic reviewPancreatology, 2018
- Pancreatic Atrophy Relative to External Versus Internal Drainage of the Pancreatic Duct After Pylorus-Preserving PancreaticoduodenectomyJournal of Gastrointestinal Surgery, 2014
- Positionspapier: Exokrine Pankreasinsuffizienz und Diabetes mellitusWiener klinische Wochenschrift, 2012
- Pancrelipase Delayed-Release Capsules (CREON) for Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-Blind Randomized TrialAmerican Journal of Gastroenterology, 2010
- Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitusActa Diabetologica, 2000